Published online January 2, 2007
PEDIATRICS Vol. 119 No. 1 January 2007, pp. e124-e130 (doi:10.1542/peds.2006-1222)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Savino, F.
Right arrow Articles by Miniero, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Savino, F.
Right arrow Articles by Miniero, R.
Related Collections
Right arrow Therapeutics & Toxicology

ARTICLE

Lactobacillus reuteri (American Type Culture Collection Strain 55730) Versus Simethicone in the Treatment of Infantile Colic: A Prospective Randomized Study

Francesco Savino, MD, Emanuela Pelle, MD, Elisabetta Palumeri, MD, Roberto Oggero, MD and Roberto Miniero, MD

Department of Pediatrics, Regina Margherita Children's Hospital, University of Turin, Turin, Italy

OBJECTIVE. The goal was to test the hypothesis that oral administration of Lactobacillus reuteri in a prospective randomized study would improve symptoms of infantile colic.

METHODS. Ninety breastfed colicky infants were assigned randomly to receive either the probiotic L reuteri (108 live bacteria per day) or simethicone (60 mg/day) each day for 28 days. The mothers avoided cow's milk in their diet. Parents monitored daily crying times and adverse effects by using a questionnaire.

RESULTS. Eighty-three infants completed the trial: 41 in the probiotic group and 42 in the simethicone group. The infants were similar regarding gestational age, birth weight, gender, and crying time at baseline. Daily median crying times in the probiotic and simethicone groups were 159 minutes/day and 177 minutes/day, respectively, on the seventh day and 51 minutes/day and 145 minutes/day on the 28th day. On day 28, 39 patients (95%) were responders in the probiotic group and 3 patients (7%) were responders in the simethicone group. No adverse effects were reported.

CONCLUSIONS. In our cohort, L reuteri improved colicky symptoms in breastfed infants within 1 week of treatment, compared with simethicone, which suggests that probiotics may have a role in the treatment of infantile colic.

Key Words: gut microflora • Lactobacillus reuteri • simethicone • infantile colic

Accepted Aug 8, 2006.




This article has been cited by other articles:


Home page
 Appl. Environ. Microbiol.Home page
K. Whitehead, J. Versalovic, S. Roos, and R. A. Britton
Genomic and Genetic Characterization of the Bile Stress Response of Probiotic Lactobacillus reuteri ATCC 55730
Appl. Envir. Microbiol., March 15, 2008; 74(6): 1812 - 1819.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Med.Home page
R. Lehman
Evidently . . .
Evid. Based Med., April 1, 2007; 12(2): 35 - 35.
[Full Text] [PDF]

Home page
 Evid. Based Med.Home page
Other articles noted
Evid. Based Med., April 1, 2007; 12(2): 63 - 64.
[Full Text] [PDF]

Home page
 AAP NewsHome page
C. Kemp
Lactobacillus reuteri lessens symptoms of infantile colic
AAP News, April 1, 2007; 28(4): 2 - 2.
[Full Text] [PDF]

Home page
 JWatch PediatricsHome page
A New Treatment for Colic?
Journal Watch Pediatrics and Adolescent Medicine, January 24, 2007; 2007(124): 2 - 2.
[Full Text]

Home page
 JWatch GeneralHome page
A New Treatment for Colic?
Journal Watch (General), January 18, 2007; 2007(118): 5 - 5.
[Full Text]